Beijing Zhifei Lvzhu Biopharmaceutical Co.,Ltd

No.22 Tongji North Road, Beijing Economic and Technological Development Zone, Beijing, 北京市, China

Clinical Trials

9 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

45.5%

Phase 1

36.4%

Phase 2

13.6%

Not Applicable

4.5%

Trial Status Distribution

Active, not recruiting

22.7%

Completed

27.3%

Enrolling By Invitation

4.5%

Not yet recruiting

13.6%

Recruiting

13.6%

Unknown

18.2%

Clinical Trials

Trials sponsored by this organization (22)

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Phase 3

Recruiting

interventional

Dec 20231,584 participants

Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)

Phase 1

Recruiting

interventional

Jul 2023300 participants

Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine

Not Applicable

Recruiting

interventional

Jul 20232,346 participants

Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23

Phase 3

Active, not recruiting

interventional

Jan 2023990 participants

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

Phase 3

Active, not recruiting

interventional

Dec 20211,200 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

Beijing Zhifei Lvzhu Biopharmaceutical Co.,Ltd

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (22)

A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60

Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)

Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine

Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

Approvals

News